BioCentury
ARTICLE | Clinical News

LXN regulatory update

July 27, 1998 7:00 AM UTC

LXN received U.S. Patent No. 5,762,871 covering a multi-layer test device that measures glucose and fructosamine in diabetic blood samples. ...